Introducing "Molecular Classification/ProMise," the fourth and final video of our Beyond the Stories video series, funded by Michael Smith Health Research BC.

This video features Dr. Jessica McAlpine, Dr. Amy Jamieson, and GCI Patient Partners Stephani and Margaret as they discuss the ProMisE molecular classification system and the value of tailoring treatments to the patient.

ProMisE is a molecular classification system that uses simple low-cost tests to consistently categorize endometrial cancers, provides prognostic information, and directs what treatments might be more effective. This system was developed by Dr. Jessica McAlpine and her team here in BC.

-----------------------
Learn more about the GCI: https://gynecancerinitiative.ca
Learn more about MSFHR: https://www.msfhr.org

Follow us on social media!
Twitter - https://bit.ly/3jsViHM (@GCI_Cluster)
Instagram - https://bit.ly/3dRQsCF (@gynecancerinitiative)
Facebook - https://bit.ly/3knUgOw